Hughes & Company Closes $260M Fund II to Innovate Healthcare Solutions
- Hughes & Company closed its second fund, raising $260 million to invest in healthcare innovation and efficiency.
- Founded in 2010, Hughes & Company previously closed its first fund at $116 million, achieving successful exits.
- The firm’s first investment from Fund II involves a merger between Curvo and BroadJump to enhance healthcare analytics.
Hughes & Company Closes Second Fund to Drive Innovation in Healthcare
Hughes & Company, a private equity firm focused on healthcare software and technology-enabled services, successfully closes its second private equity fund, Hughes Growth Equity Fund II, L.P., at a hard cap of $260 million, exceeding its initial target of $200 million. This achievement reflects the firm’s strong reputation and commitment to enhancing the healthcare landscape. Managing Partner and Founder, Travis Hughes, expresses gratitude towards both existing and new investors, emphasizing the firm’s dedication to investing in companies that lower costs and improve operational efficiency within the healthcare sector.
With its founding dating back to 2010, Hughes & Company has established a solid track record, evidenced by the successful closure of its first fund, Hughes Growth Equity Fund I, L.P., in 2021 at $116 million. This initial fund has supported several growth-stage companies and has recently seen a lucrative exit with the sale of its investment in Azara Healthcare to Insight Partners in late 2024. Such strategic exits not only highlight the firm’s ability to identify promising investments but also its commitment to fostering growth and innovation in the healthcare sector. The firm’s investment team, composed of industry experts, focuses on enhancing the operational capabilities and culture of the companies it partners with, ensuring that they can deliver lasting value to the healthcare system.
In its mission to drive innovation, Hughes & Company has already made its first investment from Fund II by orchestrating a merger between Curvo and BroadJump. This merger aims to create a comprehensive spend management and analytics platform that caters specifically to hospitals and health systems. By combining their strengths, Curvo and BroadJump are set to enhance operational outcomes and reduce costs, aligning perfectly with Hughes & Company's objective of investing in solutions that improve patient care and healthcare efficiency. This proactive approach positions Hughes & Company as a pivotal player in the ongoing transformation of the healthcare industry.
In addition to its recent fund closing, Hughes & Company’s ongoing commitment to strategic growth is evident in its ability to identify and support innovative healthcare companies. The firm continues to prioritize investments that contribute to a more efficient healthcare system, demonstrating a clear alignment with market needs. As the healthcare landscape evolves, Hughes & Company remains poised to leverage its expertise and resources to drive meaningful change and add value to the companies it partners with.
